The Trends of Cardiovascular and Cancer Mortality in Russian Men and Women from 2000 to 2016 years

Aim. To compare trends from CVD and cancer mortality in the Russian Federation from 2000 to 2016. depending on age and gender.

Material and methods. The official statistics on mortality of Federal state statistics Service and the data obtained in the Russian database of fertility and mortality of the Center for Demographic Studies of the Russian Economic School, Moscow (Russia) were used. Mortality from CVD, including coronary heart disease (CHD), cerebrovascular disease (CerVD), other CVD, and cancer, including prostate cancer in men and breast cancer in women, stomach cancer, trachea, bronchus and lung cancer were analyzed from 2000 to 2016.

Results. From 2000 to 2016 CVD mortality leads in comparison with deaths from cancer both in absolute number of deaths and in standardized deaths rates (SDR). There was a decrease in SDR from CVD and cancer between 2003 and 2016, however, rate of decline in the mortality rate from cancer was much less pronounced compared to CVD. At the same time, there is a trend towards a convergence in mortality from both causes in all age groups, with the exception of 75 years and older. For women in the age group of 35–64 years in 2016, the SDR from CVD was slightly lower than from cancer. The decrease in mortality from CVD was accompanied by a decrease in mortality from CHD and the CerVD, the latter was more pronounced in women. The overall mortality rate from cancer was characterized by a decrease in gastric cancer in people of both sexes, trachea, bronchus and lung cancer in men and breast cancer in women and an increase in prostate cancer in men.

Conclusion. The ratio of mortality of CVD to cancer and their age characteristics are important for health care. Keeping in mind a present high rate of CVD deaths and cancer deaths rate decline is still not enough, there are now already two big problems for the health care and prevention is a key, especially with common risk factors. These changing trends in mortality may support evidence for changes in the policy of resource allocation in the country. 

1. Ford E.S., Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu ev Public Health. 2011;32:5-22. doi:10.1146/annurev-publhealth-031210-101211.

2. Townsend N., Wilson L., Bhatnagar P. et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232-45. doi:10.1093/eurheartj/ehw334.

3. Bosetti C., Bertuccio P., Malvezzi M. et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Annals of Oncology. 2013;24:2657-71. doi:10.1093/annonc/mdt301.

4. Torre L.A., Siegel R.L., Ward E.M., Jemal A. Global Cancer Incidence and Mortality Rates and TrendsAn Update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16-27. doi:10.1158/1055-9965.EPI15-0578.

5. Wilson L., Bhatnagar P., Townsend N. Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983-2013: joinpoint regression analysis. Popul Health Metr. 2017;15(1):23. doi:10.1186/s12963-017-0141-5.

6. Nichols M., Townsend N., Scarborough P., Rayner M. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J. 2013;34(39):3017- 27. doi:10.1093/eurheartj/eht159.

7. Pereira M., Peleteiro B., Capewell S. et al. Changing patterns of cardiovascular diseases and cancer mortality in Portugal, 1980-2010. BMC Public Health. 2012;12:1126. doi:10.1186/1471-2458- 12-1126.

8. Federal states statistics service. The demographic yearbook of Russia. Statistical handbook. Moscow: Rosstat; 2017. (In Russ.) [Демографический ежегодник России (2017). Москва: Росстат; 2017].

9. Russian Fertility and Mortality Database. Center for Demographic Research, Moscow (Russia). [cited by Feb 10, 2019]. Available from: http://demogr.nes.ru/index.php/ru/demogr_indicat/data. (In Russ.).

10. Kaprin A.P., Starinskii V.V., Petrova G.V., eds. Malignant neoplasms in Russia in 2017 (morbidity and mortality). Moscow: MNIOI n.a. P.A. Herzen; 2018. (In Russ.)

11. Trapeznikov N.N., Kushlinskij N.E. Potential killer number one. Bulletin of the Russian Academy of Sciences. 2001;71(6):503-9 (In Russ.)

12. Timonin S.A. Oncology mortality in Russia. Demoscope Weekly (2013) [cited by Feb 10, 2019]. Available from: ;557-578. Russian. http://www.demoscope.ru/weekly/2013/0577/tema05.php].

13. Unal B., Critchley J.A., Capewell S. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. BMJ. 2005;331(7517):614. doi:10.1136/bmj.38561.633345.8F.

14. Ford E.S., Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annul Rev Public Health. 2011;32:5-22. doi:10.1146/annurev-publhealth-031210-101211.

15. Laatikainen T., Critchley J., Vartiainen E. et al. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005;162:764-73. doi:10.1093/aje/kwi274.

16. Marshall D.C., Webb T.E., Hall R.A. et al. Trends in UK regional cancer mortality 1991-2007. Br J Cancer. 2016;114(3):340-7. doi:10.1038/bjc.2015.428.

17. Jatoi I., Miller A.B. Why is breast-cancer mortality declining? Lancet Oncol. 2003;4(4):251-4. doi:10.1016/S1470-2045(03)01037-4.

18. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287-323. doi:10.1016/S0140-6736(15)00128-2.

19. Arriaga M.E., Vajdic C.M., Canfell K. et al The burden of cancer attributable to modifiable risk factors: the Australian cancer-PAF cohort consortium BMJ Open. 2017;7:e016178. doi:10.1136/bmjopen2017-016178.

20. Muromtseva G.A., Kontsevaya A.V., Konstantinov V.V. et al. The prevalence of non-infectious diseases risk factors in Russian population in 2012-2013 years. The results of ESSE-RF Cardiovascular Therapy and Prevention. 2014;13(6):4-11. (In Russ.) doi:10.15829/1728-8800-2014-6-4-11.

21. Lu Y., Hajifathalian K., Ezzati M. et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014;383(9921):970-83. doi:10.1016/S0140- 6736(13)61836-X.

22. Bhaskaran K., Douglas I., Forbes H. et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014;384(9945):755-65. doi:10.1016/S0140-6736(14)60892-8.